Company Overview and News

 
Subdued but improving oil and gas industry in 2016

2016-12-18 themalaymailonline
The decline in oil prices has forced the government to recalibrate the 2016 Budget. — AFP picKUALA LUMPUR, Dec 18 — The oil and gas industry endured another challenging year in 2016 as the global supply glut continued to haunt the market, pushing global crude oil prices to their lows.

 
Breakfast briefing: Thursday, November 3

2016-11-03 thestar.com.my
MarketWrap: The S&P 500 ended lower on Wednesday for a seventh straight session, its longest such streak in five years, as the Federal Reserve signalled it could hike interest rates in December and the uncertain US election continued to cloud the market's outlook. - Reuters The DJIA fell 77.46 points, or 0.43%, to close at 17,959.64, the S&P 500 lost 13.78 points, or 0.65%, to finish at 2,097.94 and the Nasdaq dropped 48.

 
Monies to be returned to Cliq Energy’s shareholders on Nov 14

2016-11-02 thestar.com.my
Cliq had proposed to buy a 51% stake in a special-purpose vehicle that will host Phystech Firm LLP's two onshore Kazakhstan oilfields but the application was returned by the SC due to incomplete information submission. The photo shows Phystech's manifold and testing facility at an oilfield in Kazakhstan.

 
Reach crosses another hurdle

2016-10-21 thestar.com.my
This file picture taken on 15 August 2014 shows Reach Energy Bhd MD Ir Shahul Hamid Mohd Ismail viewing the board of the stock exchange as the largest oil and gas SPAC Reach Energy Bhd debut on the Bursa Malaysia

 
Dream within Reach

2016-10-01 thestar.com.my
Shahul: ‘I have been in the industry for more than thirty years. This is not for the glory. Consider this my national service to Malaysia.’

 
Breakfast briefing: Thursday, September 29

2016-09-29 thestar.com.my
MarketWrap: Wall Street ended higher on Wednesday after an Opec agreement to limit crude output fuelled a rally in oil and more than offset nervousness about a tight race for the US presidency. - Reuters The DJIA rose 0.61% to end at 18,339.24 points, the S&P 500 gained 0.53% to 2,171.37 and the Nasdaq added 0.24% to 5,318.55. Forex summary *The ringgit gained 0.56% to 4.1150 per US$ *It was 0.46% higher at 4.

 
KLCI struggles to sustain gains as region backpedals

2016-09-28 theedgemarkets
KUALA LUMPUR (Sept 28): The FBM KLCI struggled to sustain its gains in the morning session today, as regional market back-pedalled and local sentiment turned tepid.

 
KLCI struggles to sustain gains as region back pedals

2016-09-28 theedgemarkets
KUALA LUMPUR (Sept 28): The FBM KLCI struggled to sustain its gains in the morning session today, as regional market back-pedalled and local sentiment turned tepid.

 
KLCI to face resistance at 1,672, stay under pressure

2016-09-26 theedgemarkets
KUALA LUMPUR (Sept 27): The FBM KLCI is expected to remain under pressure today and face resistance at the 1,672 level in line with the overnight fall at most global markets.

 
UEM Edgenta, SunCon, Pestech, CLIQ, KNM, Voir and Bina Puri

2016-09-26 theedgemarkets
KUALA LUMPUR (Sept 26): Based on corporate announcements and news flow today, companies that may be in focus tomorrow (Tuesday, Sept 27) could include: UEM Edgenta, SunCon, Pestech, CLIQ, KNM, Voir and Bina Puri.

 
Breakfast briefing: Wednesday, September 21

2016-09-21 thestar.com.my
MarketWrap: Wall Street ended little-changed on Tuesday as healthcare gains countered declines in energy shares, a day before highly anticipated outcomes of monetary policy meetings in the United States and Japan. - Reuters The DJIA rose 9.79 points, or 0.05%, to 18,129.96, the S&P 500 gained 0.64 points, or 0.03%, to 2,139.76 and the Nasdaq added 6.33 points, or 0.12%, to 5,241.35. Forex summary *The ringgit gained 0.

 
KLCI to continue trading range bound, resistance seen at 1,668

2016-09-21 theedgemarkets
KUALA LUMPUR (Sept 21): The FBM KLCI is expected to continue trading range bound today with resistance seen at 1,668 points, in line with the flat global markets.

 
Press Metal, Dagang NeXchange, KESM, CLIQ and Ekovest

2016-09-20 theedgemarkets
KUALA LUMPUR (Sept 20): Based on corporate announcements and news flow today, companies that may be in focus tomorrow (Sept 21) could include: Press Metal, Dagang NeXchange, KESM, CLIQ and Ekovest.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...